Mexico Diagnostic Labs Market by Provider Type (Hospital Based Diagnostic Labs, Diagnostic Chains, Stand Alone Diagnostic Labs), By Test Type (Pathology, Radiology), By End User (Walk-ins, Referrals, Corporate Clients), By Region, Competition, Forecast &

Mexico Diagnostic Labs Market by Provider Type (Hospital Based Diagnostic Labs, Diagnostic Chains, Stand Alone Diagnostic Labs), By Test Type (Pathology, Radiology), By End User (Walk-ins, Referrals, Corporate Clients), By Region, Competition, Forecast & Opportunities, 2018-2028F

Mexico Diagnostic Labs Market is anticipated to witness impressive growth during the forecast period, 2024-2028. This can be ascribed to the rising prevalence of various chronic diseases among populations across the country.

The growing prevalence of chronic diseases such as cardiovascular disease and cancer has led to an increase in demand for diagnostic Labs for diagnosis purposes and monitoring treatments at different stages of the disease. According to Global Cancer Observatory, there are around 195,499 new cases of cancer reported in Mexico in 2020. Out of these cases, 89,536 new cancer cases were reported in males, and 105,963 new cancer cases were reported among females. Breast cancer, cervix uteri cancer, thyroid cancer, colorectum cancer, and corpus uteri cancer were the most prevalent five types of cancer among women in the country. In males, the most prevalent five types of cancers reported in 2020 were prostate cancer, colorectum cancer, stomach cancer, lung cancer, and non-Hodgkin lymphoma. These statistics illustrate the requirement for regular diagnosis and mandatory check-ups, thereby boosting the growth of the Mexico Diagnostic Labs market.

Rising Prevalence of Cardiovascular Diseases

According to the Global Burden of Disease statistics, in 2020-2021, Mexico reported ischemic heart disease as the leading cause of mortality among the population after the COVID-19 mortality cases. In 2021, 164,461 deaths occurred in the country due to ischemic heart disease conditions, followed by the prevalence of diabetes mellitus causing 143,020 deaths. Diseases such as Cerebrovascular disease, Hypertensive diseases, Malignant neoplasms, Digestive diseases, and Respiratory infections are highly prevalent in Mexico and thereby are creating a higher demand for the diagnostic labs required for diagnosis and regular monitoring of the disease and symptoms, thus providing the Mexico Diagnostic Labs Market a lucrative growth.

Increased Testing for Infectious Diseases

In Mexico, Hepatitis A Virus (HAV) infection is among the leading viral hepatitis among children of age 1-9 years, as the vaccine is yet not included in the national immunization program (NIP) in Mexico. To confirm the hepatitis A Virus, serological testing is performed, which further detects the presence of Immunoglobulin M (IgM) anti-HAV in the convalescent phase of the infection. Underdiagnosis, the IgM antibodies indicate recent infection, and IgG antibodies indicate past infection and usually persist throughout an individual’s lifespan after infection or vaccination. The increased testing for Hepatitis A Virus (HAV) infection is giving a boost to the Mexico diagnostic Labs Market growth. The rising incidence of infectious diseases such as typhoid, malaria, herpes simplex, HIV/AIDS, and skin diseases is expected to raise the demand for distinct microbiology and cytology tests, thereby creating a demand for Diagnostic Labs Market growth in the country.

Rising Number of Obesity Cases

Mexico is an emerging country with young demographics, with a consumption of unhealthy food and living a sedentary lifestyle; the country has reportedly observed a larger population with increasing weight and even overweight conditions. Approximately 75% of Mexico’s adult population is either obese or overweight, which makes the country one of the world’s leading countries in both adult and childhood obesity. With a growing population, the unhealthy lifestyle and Obesity-prevalence rate is also rising, giving rise to various health conditions such as heart disease, stroke, type 2 diabetes, and certain types of cancer. The sedentary lifestyle giving rise to less physical movement due to the office and the new work-from-home lifestyle along with no physical exercise is creating severe health worsening conditions such as arthritis, hypertension, heart disease, stroke, cancer, and diabetes thereby creating an essential requirement for the diagnostic and testing labs for regular check-ups and monitoring thereby driving the Mexico Diagnostic Labs market growth.

Well Established Healthcare Infrastructure

The availability of a significant number of diagnostic labs in distinct regions of Mexico has aided the healthcare system in Mexico. Mexico ranks second in the Americas on account of a number of accredited labs. The number of accredited labs in Mexico was 18 on count till 2005, which rose to a higher count of 81 in 2015. Mexico has a social security system that provides health insurance to all the formal workers and their families. For people outside the formal workforce, the public insurance scheme Seguro Popular provided insurance coverage for millions of low-income Mexicans until its current replacement by Instituto de Salud para El Bienestar in January 2020. The new system Instituto de Salud para El Bienestar is subjected to aim to decentralize and integrate distinct public healthcare institutions to provide free healthcare to all Mexicans in a more efficient and integrated manner and thus providing more routine healthcare and diagnostic facilities to the country's people, thereby boosting the Mexico Diagnostic Labs Market.

Market Segmentation

Mexico Diagnostic Labs Market is segmented into Provider Type, test type, end users, and region. Based on product type, the market can be segmented into Hospital Based Diagnostic Labs, Diagnostic Chains, and Stand-Alone Diagnostic Labs. Depending on the Test type, the market can be segmented into Pathology and Radiology. Based on end users, the market can be differentiated into Walk-ins, Referrals, and Corporate Clients.

Market Players

Laboratorio Médico del Chopo, Estudios Clínicos Dr. T.J. Oriard SA de CV, Quest Diagnostics Incorporated, Diagno, Salud Digna, Omicron Lab (Omnigenomics), Lans Laboratorios de Referencia, S.A. de C.V., etc. are some of the leading players operating in the Mexico Diagnostic Labs Market.

Report Scope:

In this report, Mexico Diagnostic Labs Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

• Mexico Diagnostic Labs Market, By Provider Type:
• Hospital Based Diagnostic Labs
• Diagnostic Chains
• Stand Alone Diagnostic Labs
• Mexico Diagnostic Labs Market, By Test Type:
• Pathology
• Radiology
• Mexico Diagnostic Labs Market, By End User:
• Walk-ins
• Referrals
• Corporate Clients
• Mexico Diagnostic Labs Market, By Region
• North
• Central Mexico
• Central North
• South Mexico

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Mexico Diagnostic Labs Market.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights